Anthocyanins, anthocyanin derivatives, and colorectal cancer

Li Shu Wang, Chieh Ti Kuo, Dan Peiffer, Claire Seguin, Kristen Stoner, Yi Wen Huang, Hui-ming Huang, Nita Salzman, Zhongfa Liu, Daniel Rosenberg, Guang Yu Yang, Wencai Yang, Xiuli Bi, Steven Carmella, Stephen Hecht, Gary Stoner

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Anthocyanins are a ubiquitous group of water-soluble plant metabolites of the flavonoid family. They are “nature’s colors,” responsible for the blue, purple, red, and intermediate colors of leaves, flowers, vegetables, and fruits, especially berries. The daily intake of anthocyanins in the U.S. diet is estimated to be as much as 180–215 mg, or about ninefold higher than that of other flavonoids such as quercetin, genistein, and apigenin [1]. Epidemiological studies suggest that the consumption of anthocyanins lowers the risk for diabetes, arthritis, cardiovascular disease, and cancer due, at least in part, to their anti-inflammatory and antioxidant activities [2]. The chemistry, bioavailability, and chemopreventive effects of anthocyanins in multiple tissues have been summarized in our earlier publication [3] and will not be addressed here. This chapter focuses exclusively on mechanistic studies of the prevention of colorectal cancer with anthocyanins, including results from in vitro cell culture systems, in vivo animal model systems, and human studies. In addition, recent studies from our laboratory and those of our collaborators of the effects of anthocyanins on inflammation-associated colorectal cancer, that is ulcerative colitis, are discussed. Finally, this chapter summarizes the known chemopreventive effects of protocatechuic acid (PCA), a major metabolite of anthocyanins. Additional in vitro and in vivo studies of the potential preventative effects of PCA in animal model and human systems are recommended.

Original languageEnglish (US)
Title of host publicationAnthocyanins in Health and Disease
PublisherCRC Press
Pages225-243
Number of pages19
ISBN (Electronic)9781439894767
ISBN (Print)9781439894712
DOIs
StatePublished - Jan 1 2013

Fingerprint

Anthocyanins
colorectal neoplasms
anthocyanins
Colorectal Neoplasms
chemical derivatives
Derivatives
Flavonoids
protocatechuic acid
Metabolites
Fruit
Animals
flavonoids
Animal Models
Color
animal models
metabolites
Apigenin
Acids
Genistein
color

ASJC Scopus subject areas

  • Medicine(all)
  • Engineering(all)
  • Agricultural and Biological Sciences(all)
  • Chemistry(all)

Cite this

Wang, L. S., Kuo, C. T., Peiffer, D., Seguin, C., Stoner, K., Huang, Y. W., ... Stoner, G. (2013). Anthocyanins, anthocyanin derivatives, and colorectal cancer. In Anthocyanins in Health and Disease (pp. 225-243). CRC Press. https://doi.org/10.1201/b15554

Anthocyanins, anthocyanin derivatives, and colorectal cancer. / Wang, Li Shu; Kuo, Chieh Ti; Peiffer, Dan; Seguin, Claire; Stoner, Kristen; Huang, Yi Wen; Huang, Hui-ming; Salzman, Nita; Liu, Zhongfa; Rosenberg, Daniel; Yang, Guang Yu; Yang, Wencai; Bi, Xiuli; Carmella, Steven; Hecht, Stephen; Stoner, Gary.

Anthocyanins in Health and Disease. CRC Press, 2013. p. 225-243.

Research output: Chapter in Book/Report/Conference proceedingChapter

Wang, LS, Kuo, CT, Peiffer, D, Seguin, C, Stoner, K, Huang, YW, Huang, H, Salzman, N, Liu, Z, Rosenberg, D, Yang, GY, Yang, W, Bi, X, Carmella, S, Hecht, S & Stoner, G 2013, Anthocyanins, anthocyanin derivatives, and colorectal cancer. in Anthocyanins in Health and Disease. CRC Press, pp. 225-243. https://doi.org/10.1201/b15554
Wang LS, Kuo CT, Peiffer D, Seguin C, Stoner K, Huang YW et al. Anthocyanins, anthocyanin derivatives, and colorectal cancer. In Anthocyanins in Health and Disease. CRC Press. 2013. p. 225-243 https://doi.org/10.1201/b15554
Wang, Li Shu ; Kuo, Chieh Ti ; Peiffer, Dan ; Seguin, Claire ; Stoner, Kristen ; Huang, Yi Wen ; Huang, Hui-ming ; Salzman, Nita ; Liu, Zhongfa ; Rosenberg, Daniel ; Yang, Guang Yu ; Yang, Wencai ; Bi, Xiuli ; Carmella, Steven ; Hecht, Stephen ; Stoner, Gary. / Anthocyanins, anthocyanin derivatives, and colorectal cancer. Anthocyanins in Health and Disease. CRC Press, 2013. pp. 225-243
@inbook{b5fb140c3df14fefa45ddb39bac11d16,
title = "Anthocyanins, anthocyanin derivatives, and colorectal cancer",
abstract = "Anthocyanins are a ubiquitous group of water-soluble plant metabolites of the flavonoid family. They are “nature’s colors,” responsible for the blue, purple, red, and intermediate colors of leaves, flowers, vegetables, and fruits, especially berries. The daily intake of anthocyanins in the U.S. diet is estimated to be as much as 180–215 mg, or about ninefold higher than that of other flavonoids such as quercetin, genistein, and apigenin [1]. Epidemiological studies suggest that the consumption of anthocyanins lowers the risk for diabetes, arthritis, cardiovascular disease, and cancer due, at least in part, to their anti-inflammatory and antioxidant activities [2]. The chemistry, bioavailability, and chemopreventive effects of anthocyanins in multiple tissues have been summarized in our earlier publication [3] and will not be addressed here. This chapter focuses exclusively on mechanistic studies of the prevention of colorectal cancer with anthocyanins, including results from in vitro cell culture systems, in vivo animal model systems, and human studies. In addition, recent studies from our laboratory and those of our collaborators of the effects of anthocyanins on inflammation-associated colorectal cancer, that is ulcerative colitis, are discussed. Finally, this chapter summarizes the known chemopreventive effects of protocatechuic acid (PCA), a major metabolite of anthocyanins. Additional in vitro and in vivo studies of the potential preventative effects of PCA in animal model and human systems are recommended.",
author = "Wang, {Li Shu} and Kuo, {Chieh Ti} and Dan Peiffer and Claire Seguin and Kristen Stoner and Huang, {Yi Wen} and Hui-ming Huang and Nita Salzman and Zhongfa Liu and Daniel Rosenberg and Yang, {Guang Yu} and Wencai Yang and Xiuli Bi and Steven Carmella and Stephen Hecht and Gary Stoner",
year = "2013",
month = "1",
day = "1",
doi = "10.1201/b15554",
language = "English (US)",
isbn = "9781439894712",
pages = "225--243",
booktitle = "Anthocyanins in Health and Disease",
publisher = "CRC Press",

}

TY - CHAP

T1 - Anthocyanins, anthocyanin derivatives, and colorectal cancer

AU - Wang, Li Shu

AU - Kuo, Chieh Ti

AU - Peiffer, Dan

AU - Seguin, Claire

AU - Stoner, Kristen

AU - Huang, Yi Wen

AU - Huang, Hui-ming

AU - Salzman, Nita

AU - Liu, Zhongfa

AU - Rosenberg, Daniel

AU - Yang, Guang Yu

AU - Yang, Wencai

AU - Bi, Xiuli

AU - Carmella, Steven

AU - Hecht, Stephen

AU - Stoner, Gary

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Anthocyanins are a ubiquitous group of water-soluble plant metabolites of the flavonoid family. They are “nature’s colors,” responsible for the blue, purple, red, and intermediate colors of leaves, flowers, vegetables, and fruits, especially berries. The daily intake of anthocyanins in the U.S. diet is estimated to be as much as 180–215 mg, or about ninefold higher than that of other flavonoids such as quercetin, genistein, and apigenin [1]. Epidemiological studies suggest that the consumption of anthocyanins lowers the risk for diabetes, arthritis, cardiovascular disease, and cancer due, at least in part, to their anti-inflammatory and antioxidant activities [2]. The chemistry, bioavailability, and chemopreventive effects of anthocyanins in multiple tissues have been summarized in our earlier publication [3] and will not be addressed here. This chapter focuses exclusively on mechanistic studies of the prevention of colorectal cancer with anthocyanins, including results from in vitro cell culture systems, in vivo animal model systems, and human studies. In addition, recent studies from our laboratory and those of our collaborators of the effects of anthocyanins on inflammation-associated colorectal cancer, that is ulcerative colitis, are discussed. Finally, this chapter summarizes the known chemopreventive effects of protocatechuic acid (PCA), a major metabolite of anthocyanins. Additional in vitro and in vivo studies of the potential preventative effects of PCA in animal model and human systems are recommended.

AB - Anthocyanins are a ubiquitous group of water-soluble plant metabolites of the flavonoid family. They are “nature’s colors,” responsible for the blue, purple, red, and intermediate colors of leaves, flowers, vegetables, and fruits, especially berries. The daily intake of anthocyanins in the U.S. diet is estimated to be as much as 180–215 mg, or about ninefold higher than that of other flavonoids such as quercetin, genistein, and apigenin [1]. Epidemiological studies suggest that the consumption of anthocyanins lowers the risk for diabetes, arthritis, cardiovascular disease, and cancer due, at least in part, to their anti-inflammatory and antioxidant activities [2]. The chemistry, bioavailability, and chemopreventive effects of anthocyanins in multiple tissues have been summarized in our earlier publication [3] and will not be addressed here. This chapter focuses exclusively on mechanistic studies of the prevention of colorectal cancer with anthocyanins, including results from in vitro cell culture systems, in vivo animal model systems, and human studies. In addition, recent studies from our laboratory and those of our collaborators of the effects of anthocyanins on inflammation-associated colorectal cancer, that is ulcerative colitis, are discussed. Finally, this chapter summarizes the known chemopreventive effects of protocatechuic acid (PCA), a major metabolite of anthocyanins. Additional in vitro and in vivo studies of the potential preventative effects of PCA in animal model and human systems are recommended.

UR - http://www.scopus.com/inward/record.url?scp=85054214291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054214291&partnerID=8YFLogxK

U2 - 10.1201/b15554

DO - 10.1201/b15554

M3 - Chapter

SN - 9781439894712

SP - 225

EP - 243

BT - Anthocyanins in Health and Disease

PB - CRC Press

ER -